NASDAQ: TFFPTff Pharmaceuticals Inc Stock Ownership - Who owns Tff Pharmaceuticals?
Insider buying vs selling
Have Tff Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Carlson Capital L P | 10% Owner | 2023-08-16 | 1,000 | $0.39 | $392.00Sell |
| Kirk Allen Coleman | Chief Financial Officer | 2023-08-15 | 20,000 | $0.25 | $5.00kBuy |
| Zamaneh Mikhak | Chief Medical Officer | 2023-08-15 | 120,000 | $0.25 | $30.00kBuy |
| Robert S. Mills | Director | 2023-08-15 | 40,000 | $0.25 | $10.00kBuy |
| Brandi Roberts | Director | 2023-08-15 | 20,000 | $0.25 | $5.00kBuy |
| Stephen Rocamboli | Director | 2023-08-15 | 20,000 | $0.25 | $5.00kBuy |
| Carlson Capital L P | 10% Owner | 2023-08-15 | 215,000 | $0.44 | $93.96kSell |
| Harlan F. Weisman | President and CEO | 2023-08-15 | 600,000 | $0.25 | $150.00kBuy |
TFFP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TFFP insiders and whales buy or sell their stock.
TFFP Shareholders
What type of owners hold Tff Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Carlson Capital L P | 209.59% | 5,280,000 | $16.10M | Insider |
| Lung Therapeutics Inc | 88.72% | 2,235,000 | $6.82M | Insider |
| Malcolm Fairbairn | 52.70% | 1,327,568 | $4.05M | Insider |
| Harlan F. Weisman | 32.34% | 814,615 | $2.48M | Insider |
| Aaron Gl Fletcher | 27.21% | 685,470 | $2.09M | Insider |
| Carlson Capital L P | 7.70% | 193,960 | $591.58k | Institution |
| Zamaneh Mikhak | 5.36% | 135,000 | $411.75k | Insider |
| Robert S. Mills | 2.22% | 55,980 | $170.74k | Insider |
| Glenn R. Mattes | 2.10% | 53,000 | $161.65k | Insider |
| Drw Securities LLC | 1.59% | 40,000 | $122.00k | Institution |
TFFP vs Biotech Stocks
Tff Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.